Interestingly, enhanced expression levels of glucose transporters GLUT1 and GLUT3 have been consistently observed across various cancers [18,19], including hepatocellular carcinoma [20,21]. This evidence concerns the gene SLC2A3 and hepatocellular carcinoma.